Lunai Bioworks Inc.
LNAINASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $2.58M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.46$7.58
- Volume (live)
- -
- Avg. volume (3M)
- 76.23K
Lunai Bioworks (LNAI) Stock Price & Financial Analysis
Lunai Bioworks Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.66 - $0.81 |
|---|---|
| 52-Week High | $7.58 |
| 52-Week Low | $0.46 |
| Open | $0.81 |
| Volume (last close) | 79.32K |
| Average Volume (3M) | 76.23K |
| Revenue (TTM) | 20.94K |
|---|---|
| Net Income (TTM) | -128.28M |
| Free Cash Flow (TTM) | -5.26M |
| EPS (TTM) | −$46.33 |
| Profit Margin | -612568.11% |
| Operating Margin | -46991.98% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 2.58M |
|---|---|
| Shares Outstanding | 3.12M |
| Price to Sales (P/S) | 123.15 |
| Price to Book (P/B) | -0.27 |
| EV/EBITDA | -0.01 |
| 50-Day MA | $2.02 |
|---|---|
| 200-Day MA | $2.20 |
| 1-Year Change | −31.21% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Lunai Bioworks at a Glance
As of the Oct 16, 2026 close, Lunai Bioworks (LNAI) has a market capitalization of $2.58M. The stock trades at 123.2× sales. Over the trailing twelve months it lost $128.28M on revenue of $20.94K and burned $5.26M of free cash flow.
As of its latest reported balance sheet, it holds $3.16M in cash and securities against $1.41M of debt, a net cash position of $1.74M.
Lunai Bioworks does not currently pay a dividend.
The share price is down 31.2% over the past year. At $0.68 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.46 to $7.58, below its 200-day moving average of $2.20.
Frequently Asked Questions About Lunai Bioworks
What is the current stock price for LNAI?
As of the Oct 16, 2026 close, LNAI stock trades at $0.68. The 52-week range is $0.46–$7.58, with a day range of $0.66–$0.81.
What is the P/E ratio for LNAI?
The P/E ratio (Price-to-Earnings) for LNAI is shown in the Key Statistics section. This valuation metric helps compare Lunai Bioworks Inc. to industry peers.
Does LNAI pay dividends?
Lunai Bioworks does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LNAI?
Analyst ratings and recommendations for LNAI are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of LNAI?
As of the Oct 16, 2026 close, Lunai Bioworks's market capitalization is $2.1M, classifying it as a micro-cap company. Lunai Bioworks operates in the Healthcare sector within the Biotechnology industry.